Skip to main content

Table 5 Analysis of the difference of NLR between tumor-free people and ESCC patients

From: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma

Group NLR level
 < 3.23  ≥ 3.23 Total
ESCC patients 60 59 119
Tumor-free people 795 14 818
Total 855 73 937
P value  < 0.05